“世界のプロテオミクス市場規模は2023年の368億ドルから2028年には729億ドルに達し、予測期間中の年平均成長率は14.6%と予測”
新しい治療薬やタンパク質ベースの医薬品を開発するための研究開発プロジェクトに対する政府資金の増加や、個別化された効率的な治療薬に対する需要の高まりなどの要因が、プロテオミクス製品&サービスの需要を支え、市場の成長を加速させています。
“2023-2028年の予測期間中、最も高いCAGRで成長が見込まれるのは、分光学分野”
装置技術に基づき、プロテオミクス市場は、分光法、クロマトグラフィー、電気泳動、タンパク質マイクロアレイ、X線結晶構造解析、表面プラズモン共鳴、タンパク質分画、その他の技術に大別されます。予測期間中、最も高いCAGRで成長すると予測されているのは分光学分野です。この成長は、タンパク質構造(サイズ、形状、二次構造、三次構造)、定量化、リガンド、溶質、他のタンパク質などの分子との相互作用を解明するためのタンパク質分析にこの技術が広く採用されていることが要因です。
“バイオチップサブセグメントは、2023-2028年の予測期間中に最も高いCAGRで成長すると予想”
装置技術のタンパク質マイクロアレイに基づいて、プロテオミクス市場はバイオチップとマイクロアレイ装置に大別されます。バイオチップセグメントは予測期間中に最も高いCAGRで成長すると予測されています。この成長は、ハイスループット分析、多重化、感度、特異性、サンプル必要量の削減、自動化など、プロテオミクス研究におけるいくつかの利点によるものです。
“製薬・バイオテクノロジー企業セグメントは、2023-2028年の予測期間中に最も高いCAGRで成長する見込み”
エンドユーザーに基づき、プロテオミクス市場は病院、臨床検査室、製薬会社、学術研究室、CDMO、CROのようなその他のエンドユーザーに区分されます。2022年のプロテオミクス市場では、製薬・バイオテクノロジー企業が圧倒的なシェアを占めています。このセグメントのシェアが高いのは、製薬大手が新分子の発見・開発のための研究開発を強化するなど、中核的な活動に注力するようになっているためです。これが市場成長を予測する主な要因の1つです。
“アジア太平洋地域はより速いペースで成長する可能性が高い”
プロテオミクス市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカに分けられます。2022年には、北米がプロテオミクス市場で圧倒的なシェアを占めています。同地域の優位性は、同地域における大手企業の存在や、新たな標的療法を開発するための継続的な研究活動など、さまざまな要因によるものです。アジア太平洋地域は、個別化治療に対する意識の高まり、同地域におけるジェネリック医薬品に対する政府のイニシアチブの高まり、プロテオミクス市場における新規参入企業の出現など、さまざまな要因により、より速いペースで成長すると考えられます。
本レポートのために実施した一次インタビューは以下のように分類できます:
– 回答者別 供給側70%、需要側30%
– 指定(供給側)別: 管理職 – 45%、CXOおよび取締役 – 30%、経営幹部 – 25%
– 地域別 北米:40%、欧州:25%、アジア太平洋地域:20%、中南米:10%、中東・アフリカ:5%
レポート掲載企業リスト
• Thermo Fisher Scientific, Inc. (US)
• Agilent Technologies, Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Waters Corporation (US)
• Bio-Rad Laboratories, Inc. (US)
• Bruker Corporation (US)
• PerkinElmer Inc. (US)
• Shimadzu Corporation (Japan)
• Illumina, Inc. (US)
• Promega Corporation (US)
• Eurofins Scientific (Luxembourg)
• QIAGEN N.V. (Germany)
• Charles River Laboratories (US)
• Protagene Protein Services (Germany)
• Creative Proteomics (US)
• HORIBA Corporation (Japan)
• Sengenics (Singapore)
• Biomax Informatics AG (Germany)
• WuXi NextCode (China)
• FIOS Genomics (UK)
• Genewiz (US)
• Medgenome Labs (India)
• Biognosys AG (Switzerland)
• Macrogen Inc. (South Korea)
調査範囲
この調査レポートは、プロテオミクス市場の詳細な市場状況を掲載しています。装置技術、試薬、ソフトウェア&サービス、アプリケーション、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの会社概要、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。
レポート購入の主な利点
本レポートは、プロテオミクス市場全体とそのサブセグメントについて、最も近似した収益数字を提供することで、市場リーダーや新規参入者を支援します。また、利害関係者が競合状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場動向を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。
本レポートは、以下のポイントに関する洞察を提供します:
– プロテオミクス市場の成長に影響を与える主な促進要因(臨床現場における個別化医薬品の需要増加、高齢者層における慢性疾患の罹患率上昇、研究投資の増加と創薬におけるプロテオミクスの採用拡大、プロテオミクスの技術進歩)、阻害要因(プロテオミクス機器および技術の高コスト、 研究グループ間でのプロテオミクスワークフローの標準化の欠如)、機会(新興国におけるプロテオミクス研究の高い成長機会、生物学的プロセスにおけるナノプロテオミクスの重要性の高まり)、および課題(プロテオミクス研究におけるバイオマーカー発見と承認の比率の低さ、プロテオミクス研究におけるデータ管理/ハンドリングの欠如)分析。
– 製品とサービスの開発/革新: 新たに発売された製品に関する詳細な洞察、プロテオミクス市場の技術評価。
– 市場開発: 有利な市場に関する包括的な情報 – 当レポートでは、さまざまな地域のプロテオミクス市場を分析。
– 市場の多様化: プロテオミクス市場における新製品・サービス、未開拓の地域、最近の開発、投資に関する詳細な情報。
– 競合評価: プロテオミクス市場におけるThermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US)など主要企業の市場シェア、成長戦略、製品&サービス展開について詳細に分析
8.3.1.1 Bioinformatics services to dominate proteomics market during study period 256
TABLE 235 BIOINFORMATICS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 257
TABLE 236 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 257
TABLE 237 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 258
TABLE 238 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 258
TABLE 239 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION 259
8.3.2 BIOINFORMATICS TOOLS 259
8.3.2.1 Increased need for data management to drive segment 259
TABLE 240 BIOINFORMATICS TOOLS MARKET, BY REGION, 2021–2028 (USD MILLION) 260
TABLE 241 NORTH AMERICA: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 260
TABLE 242 EUROPE: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 261
TABLE 243 ASIA PACIFIC: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 261
TABLE 244 LATIN AMERICA: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 262
8.3.3 BIOINFORMATICS DATABASES 262
8.3.3.1 Growing need to store proteomics data and integrate other omics databases to fuel market 262
TABLE 245 BIOINFORMATICS DATABASES MARKET, BY REGION, 2021–2028 (USD MILLION) 263
TABLE 246 NORTH AMERICA: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 264
TABLE 247 EUROPE: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 264
TABLE 248 ASIA PACIFIC: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 265
TABLE 249 LATIN AMERICA: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 265
9 PROTEOMICS MARKET, BY APPLICATION 266
9.1 INTRODUCTION 267
TABLE 250 PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 267
9.2 CLINICAL DIAGNOSTICS 267
TABLE 251 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 252 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION) 269
TABLE 253 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 269
TABLE 254 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 270
TABLE 255 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 270
TABLE 256 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 271
9.2.1 CANCER 271
9.2.1.1 Increasing investments in cancer research to drive market 271
TABLE 257 CANCER MARKET, BY REGION, 2021–2028 (USD MILLION) 272
TABLE 258 NORTH AMERICA: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 272
TABLE 259 EUROPE: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 273
TABLE 260 ASIA PACIFIC: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 273
TABLE 261 LATIN AMERICA: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 274
9.2.2 INFECTIOUS DISEASES 274
9.2.2.1 Growing prevalence of infectious diseases in emerging economices to propel market 274
TABLE 262 INFECTIOUS DISEASES MARKET, BY REGION, 2021–2028 (USD MILLION) 275
TABLE 263 NORTH AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 275
TABLE 264 EUROPE: INFECTIOUS DISEASES MARKET, BY COUNTRY 2021–2028 (USD MILLION) 276
TABLE 265 ASIA PACIFIC: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 276
TABLE 266 LATIN AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 277
9.2.3 DIABETES 277
9.2.3.1 Rising investments in diabetes research to drive market growth 277
TABLE 267 DIABETES MARKET, BY REGION, 2021–2028 (USD MILLION) 278
TABLE 268 NORTH AMERICA: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 278
TABLE 269 EUROPE: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 279
TABLE 270 ASIA PACIFIC: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 279
TABLE 271 LATIN AMERICA: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 280
9.2.4 NEUROLOGICAL DISORDERS 280
9.2.4.1 Increasing clinical trials and research in neurological disorders to fuel market 280
TABLE 272 NEUROLOGICAL DISORDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 281
TABLE 273 NORTH AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 281
TABLE 274 EUROPE: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 282
TABLE 275 ASIA PACIFIC: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 282
TABLE 276 LATIN AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 283
9.2.5 AUTOIMMUNE DISEASES 283
9.2.5.1 Increasing demand for proteomics in diagnosis of autoimmune diseases to boost market 283
TABLE 277 AUTOIMMUNE DISEASES MARKET, BY REGION, 2021–2028 (USD MILLION) 284
TABLE 278 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 284
TABLE 279 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 285
TABLE 280 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 285
TABLE 281 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 286
9.2.6 CARDIOVASCULAR DISEASES 286
9.2.6.1 High burden of cardiovascular diseases globally to increase development of more reliable proteomics tools 286
TABLE 282 CARDIOVASCULAR DISEASES MARKET, BY REGION, 2021–2028 (USD MILLION) 287
TABLE 283 NORTH AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 287
TABLE 284 EUROPE: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 288
TABLE 285 ASIA PACIFIC: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 288
TABLE 286 LATIN AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 289
9.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS 289
TABLE 287 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 290
TABLE 288 NORTH AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 290
TABLE 289 EUROPE: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 291
TABLE 290 ASIA PACIFIC: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 291
TABLE 291 LATIN AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 292
9.3 DRUG DISCOVERY & DEVELOPMENT 292
TABLE 292 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 293 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 293
TABLE 294 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 294
TABLE 295 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 294
TABLE 296 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 295
TABLE 297 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 295
9.3.1 TARGET DISCOVERY 296
9.3.1.1 Increasing demand for personalized medicine to support market 296
TABLE 298 TARGET DISCOVERY MARKET, BY REGION, 2021–2028 (USD MILLION) 297
TABLE 299 NORTH AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 297
TABLE 300 EUROPE: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 298
TABLE 301 ASIA PACIFIC: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 298
TABLE 302 LATIN AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 299
9.3.2 LEAD IDENTIFICATION 299
9.3.2.1 Lead identification to be most revenue-generating process among drug discovery & development processes 299
TABLE 303 LEAD IDENTIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 300
TABLE 304 NORTH AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 300
TABLE 305 EUROPE: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 301
TABLE 306 ASIA PACIFIC: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 301
TABLE 307 LATIN AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 302
9.3.3 LEAD OPTIMIZATION 302
9.3.3.1 Lead optimization to require state-of-the-art informatics systems for transparent presentation and analysis 302
TABLE 308 LEAD OPTIMIZATION MARKET, BY REGION, 2021–2028 (USD MILLION) 303
TABLE 309 NORTH AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 303
TABLE 310 EUROPE: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 304
TABLE 311 ASIA PACIFIC: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 304
TABLE 312 LATIN AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 305
9.3.4 PRECLINICAL STUDIES 305
9.3.4.1 Preclinical studies to facilitate transparent presentation and analysis of latest data for rapid reprioritization of synthetic targets 305
TABLE 313 PRECLINICAL STUDIES MARKET, BY REGION, 2021–2028 (USD MILLION) 306
TABLE 314 NORTH AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 306
TABLE 315 EUROPE: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 307
TABLE 316 ASIA PACIFIC: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 307
TABLE 317 LATIN AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 308
9.4 OTHER APPLICATIONS 308
TABLE 318 PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 309
TABLE 319 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 309
TABLE 320 EUROPE: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 310
TABLE 321 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 310
TABLE 322 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 311
10 PROTEOMICS MARKET, BY END USER 312
10.1 INTRODUCTION 313
TABLE 323 PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 313
10.2 HOSPITALS 313
10.2.1 RISING ADOPTION OF PROTEOMICS FOR DISEASE DIAGNOSIS TO DRIVE MARKET 313
TABLE 324 PROTEOMICS MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 314
TABLE 325 NORTH AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 315
TABLE 326 EUROPE: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 315
TABLE 327 ASIA PACIFIC: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 316
TABLE 328 LATIN AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 316
10.3 CLINICAL LABORATORIES 317
10.3.1 INCREASING OUTSOURCING OF DIAGNOSTICS TESTS BY HOSPITALS TO SUPPORT SEGMENT 317
TABLE 329 PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 318
TABLE 330 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 318
TABLE 331 EUROPE: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 319
TABLE 332 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 319
TABLE 333 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 320
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 320
10.4.1 RISING FOCUS ON DRUG DISCOVERY IN BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DRIVE MARKET 320
TABLE 334 PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 321
TABLE 335 NORTH AMERICA: PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 321
TABLE 336 EUROPE: PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 322
TABLE 337 ASIA PACIFIC: PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 322
TABLE 338 LATIN AMERICA: PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 323
10.5 ACADEMIC RESEARCH LABORATORIES 323
10.5.1 INCREASING RESEARCH FUNDING FOR PRECISION MEDICINES TO AUGMENT MARKET 323
TABLE 339 PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 324
TABLE 340 NORTH AMERICA: PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 324
TABLE 341 EUROPE: PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 325
TABLE 342 ASIA PACIFIC: PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 325
TABLE 343 LATIN AMERICA: PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 326
10.6 OTHER END USERS 326
TABLE 344 PROTEOMICS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 327
TABLE 345 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 327
TABLE 346 EUROPE: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 328
TABLE 347 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 328
TABLE 348 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 329
11 PROTEOMICS MARKET, BY REGION 330
11.1 INTRODUCTION 331
TABLE 349 PROTEOMICS MARKET, BY REGION, 2021–2028 (USD MILLION) 331
11.2 NORTH AMERICA 332
11.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION 333
FIGURE 30 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT 333
TABLE 350 NORTH AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 334
TABLE 351 NORTH AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 334
TABLE 352 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 353 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 354 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 355 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 356 NORTH AMERICA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 357 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 337
TABLE 358 NORTH AMERICA: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 337
TABLE 359 NORTH AMERICA: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 338
TABLE 360 NORTH AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 338
TABLE 361 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 339
TABLE 362 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 339
TABLE 363 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 340
TABLE 364 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 340
TABLE 365 NORTH AMERICA: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 341
11.2.2 US 341
11.2.2.1 US to dominate North American proteomics market during forecast period 341
TABLE 366 US: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 342
TABLE 367 US: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 343
TABLE 368 US: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 343
TABLE 369 US: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 370 US: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 371 US: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 372 US: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 345
TABLE 373 US: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 345
TABLE 374 US: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 346
TABLE 375 US: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 346
TABLE 376 US: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 377 US: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 347
TABLE 378 US: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 379 US: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 380 US: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 349
11.2.3 CANADA 349
11.2.3.1 Strong infrastructure and increased availability of funding for biomedical research to support market 349
TABLE 381 CANADA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 350
TABLE 382 CANADA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 350
TABLE 383 CANADA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 351
TABLE 384 CANADA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 351
TABLE 385 CANADA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, 2021–2028 (USD MILLION) 352
TABLE 386 CANADA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 352
TABLE 387 CANADA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 352
TABLE 388 CANADA: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 353
TABLE 389 CANADA: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 353
TABLE 390 CANADA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 391 CANADA: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 392 CANADA: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 355
TABLE 393 CANADA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 355
TABLE 394 CANADA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 356
TABLE 395 CANADA: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 356
11.3 EUROPE 357
11.3.1 EUROPE: IMPACT OF RECESSION 357
TABLE 396 EUROPE: PROTEOMICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 358
TABLE 397 EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 358
TABLE 398 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 359
TABLE 399 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 359
TABLE 400 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 401 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 402 EUROPE: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 403 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 361
TABLE 404 EUROPE: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 361
TABLE 405 EUROPE: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 362
TABLE 406 EUROPE: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 362
TABLE 407 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 363
TABLE 408 EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 363
TABLE 409 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 364
TABLE 410 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 364
TABLE 411 EUROPE: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 365
11.3.2 GERMANY 365
11.3.2.1 Germany to be largest market for proteomics in European region during forecast period 365
TABLE 412 GERMANY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 366
TABLE 413 GERMANY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 366
TABLE 414 GERMANY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 367
TABLE 415 GERMANY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 367
TABLE 416 GERMANY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 368
TABLE 417 GERMANY: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 368
TABLE 418 GERMANY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 368
TABLE 419 GERMANY: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 369
TABLE 420 GERMANY: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 369
TABLE 421 GERMANY: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 370
TABLE 422 GERMANY: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 370
TABLE 423 GERMANY: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 371
TABLE 424 GERMANY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 371
TABLE 425 GERMANY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 372
TABLE 426 GERMANY: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 372
11.3.3 UK 373
11.3.3.1 High prevalence of cancer and growth in life science industry to fuel market 373
TABLE 427 UK: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY 2021–2028 (USD MILLION) 374
TABLE 428 UK: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 374
TABLE 429 UK: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 375
TABLE 430 UK: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 375
TABLE 431 UK: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 375
TABLE 432 UK: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 376
TABLE 433 UK: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 376
TABLE 434 UK: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 377
TABLE 435 UK: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 377
TABLE 436 UK: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 378
TABLE 437 UK: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 378
TABLE 438 UK: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 379
TABLE 439 UK: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 379
TABLE 440 UK: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 380
TABLE 441 UK: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 380
11.3.4 FRANCE 381
11.3.4.1 Development of new proteomics-based diagnostic tools and investments in life science R&D to drive market 381
TABLE 442 FRANCE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 382
TABLE 443 FRANCE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 382
TABLE 444 FRANCE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 383
TABLE 445 FRANCE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 383
TABLE 446 FRANCE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 384
TABLE 447 FRANCE: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 384
TABLE 448 FRANCE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 384
TABLE 449 FRANCE: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 385
TABLE 450 FRANCE: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 385
TABLE 451 FRANCE: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 386
TABLE 452 FRANCE: PROTEOMICS MARKET, FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 386
TABLE 453 FRANCE: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 387
TABLE 454 FRANCE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 387
TABLE 455 FRANCE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 388
TABLE 456 FRANCE: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 388
11.3.5 SWITZERLAND 389
11.3.5.1 Well-established pharmaceutical & biotechnology industry and increased investments in life science R&D infrastructure to augment market 389
TABLE 457 SWITZERLAND: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 390
TABLE 458 SWITZERLAND: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 390
TABLE 459 SWITZERLAND: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 391
TABLE 460 SWITZERLAND: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 391
TABLE 461 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 392
TABLE 462 SWITZERLAND: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 392
TABLE 463 SWITZERLAND: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 392
TABLE 464 SWITZERLAND: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 393
TABLE 465 SWITZERLAND: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 393
TABLE 466 SWITZERLAND: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 394
TABLE 467 SWITZERLAND: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 394
TABLE 468 SWITZERLAND: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 395
TABLE 469 SWITZERLAND: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 395
TABLE 470 SWITZERLAND: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 396
TABLE 471 SWITZERLAND: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 396
11.3.6 ITALY 397
11.3.6.1 Increase in federal grants and private funding programs to support projects on translational research 397
TABLE 472 ITALY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 397
TABLE 473 ITALY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 398
TABLE 474 ITALY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 398
TABLE 475 ITALY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 399
TABLE 476 ITALY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 399
TABLE 477 ITALY: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 399
TABLE 478 ITALY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 400
TABLE 479 ITALY: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 400
TABLE 480 ITALY: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 401
TABLE 481 ITALY: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 401
TABLE 482 ITALY: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 402
TABLE 483 ITALY: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 402
TABLE 484 ITALY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 403
TABLE 485 ITALY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 403
TABLE 486 ITALY: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 404
11.3.7 SPAIN 404
11.3.7.1 Well-established network of research centers, universities, and hospitals to aid proteomics research 404
TABLE 487 SPAIN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 405
TABLE 488 SPAIN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 405
TABLE 489 SPAIN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 406
TABLE 490 SPAIN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 406
TABLE 491 SPAIN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 407
TABLE 492 SPAIN: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 407
TABLE 493 SPAIN: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 407
TABLE 494 SPAIN: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 408
TABLE 495 SPAIN: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 408
TABLE 496 SPAIN: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 409
TABLE 497 SPAIN: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 409
TABLE 498 SPAIN: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 410
TABLE 499 SPAIN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 410
TABLE 500 SPAIN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 411
TABLE 501 SPAIN: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 411
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/